menu
    • menu

    Find Nateglinide manufacturers, exporters & distributors on PharmaCompass

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    16

    API Suppliers

    API Suppliers

    10

    USDMF

    US DMFs Filed

    2

    CEP/COS

    CEP/COS Certifications

    4

    JDMF

    JDMFs Filed

    7

    EU WC

    EU WC

    0

    KDMF

    KDMF

    5

    NDC API

    NDC API

    0

    VMF

    NDC API

    5

    Listed Suppliers

    Other Suppliers

    2INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    1

    EDQM

    0

    USP

    4

    JP

    6

    Others

    FINISHED DOSAGE FORMULATIONS

    45

    FDF Dossiers

    FDF Dossiers

    18

    FDA Orange Book

    FDA (Orange Book)

    8

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    1

    South Africa

    South Africa

    18

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    290RELATED EXCIPIENT COMPANIES

    485EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    6

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 342

    GLOBAL SALES INFORMATION

    US Medicaid

    14,115,104

    Annual Reports

    NA

    Regulatory FDF Prices

    NA

    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    1

    API

    0

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    7

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 105816-04-4, Starlix, Senaglinide, Starsis, Fastic, Ay-4166
    Molecular Formula
    C19H27NO3
    Molecular Weight
    317.4  g/mol
    InChI Key
    OELFLUMRDSZNSF-OFLPRAFFSA-N
    FDA UNII
    XTM4DQP5S5
    Nateglinide
    A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.
    Nateglinide is a Glinide. The mechanism of action of nateglinide is as a Potassium Channel Antagonist.
    1 2D Structure

    Nateglinide

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
    2.1.2 InChI
    InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
    2.1.3 InChI Key
    OELFLUMRDSZNSF-OFLPRAFFSA-N
    2.1.4 Canonical SMILES
    CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
    2.1.5 Isomeric SMILES
    CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    XTM4DQP5S5
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. A 4166

    2. A-4166

    3. A4166

    4. Ay 4166

    5. Ay-4166

    6. Ay4166

    7. Djn 608

    8. Fastic

    9. N-((4-isopropylcyclohexyl)carbonyl)phenylalanine

    10. Nate-glinide

    11. Nateglinide, (cis,d-phe)-isomer

    12. Nateglinide, (d-phe)-isomer

    13. Senaglinide

    14. Starlix

    15. Starsis

    2.3.2 Depositor-Supplied Synonyms

    1. 105816-04-4

    2. Starlix

    3. Senaglinide

    4. Starsis

    5. Fastic

    6. Ay-4166

    7. Nateglinide [inn]

    8. Trazec

    9. A-4166

    10. Sdz-djn-608

    11. D-nateglinide

    12. 105816-06-6

    13. Djn 608

    14. Djn-608

    15. Ay4166

    16. Mfcd00875706

    17. Sdz Djn 608

    18. Sdz-djn 608

    19. Ay 4166

    20. (2r)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic Acid

    21. N-[(trans-4-isopropylcyclohexyl)carbonyl]-d-phenylalanine

    22. A 4166

    23. Xtm4dqp5s5

    24. Chembl783

    25. 41x3pwk4o2

    26. Chebi:31897

    27. N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine

    28. Nsc-758695

    29. 105746-37-0

    30. (-)-n-(trans-4-isopropylcyclohexanecarbonyl)-d-phenylalanine

    31. N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-d-phenylalanine

    32. D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-

    33. D-phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-

    34. (r)-2-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic Acid

    35. Dsstox_cid_20687

    36. Dsstox_rid_79543

    37. N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine(nateglinide Impurity)

    38. Dsstox_gsid_40687

    39. N-((cis-4-isopropylcyclohexyl)carbonyl)-d-phenylalanine

    40. N-(trans-4-isopropylcyclohexylcarbonyl)-d-phenyl Alanine

    41. D-phenylalanine, N-((cis-4-(1-methylethyl)cyclohexyl)carbonyl)-

    42. N-((cis-4-(1-methylethyl)cyclohexyl)carbonyl)-d-phenylalanine

    43. Trans-n-((4-(1-methylethyl)cyclohexyl)carbonyl)-d-phenylalanine

    44. D-phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, Cis-

    45. D-phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, Cis-

    46. (r)-2-rel-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic Acid

    47. Smr000466372

    48. Cas-105816-04-4

    49. Nateglinida

    50. Nateglinidum

    51. Unii-41x3pwk4o2

    52. Trans-n-{[4-(1-methylethyl)cyclohexyl]carbonyl}-d-phenylalanine

    53. Ncgc00095121-01

    54. Nateglinide [usan:usp:inn:ban]

    55. Starsis (tn)

    56. Nateglinide, Starlix

    57. Ym-026

    58. Nateglinide (starlix)

    59. Nateglinide Impurity C

    60. Nateglinide Cis Impurity

    61. Nateglinide [mi]

    62. Unii-xtm4dqp5s5

    63. Nateglinide [jan]

    64. Nateglinide [usan]

    65. Nateglinide [vandf]

    66. Nateglinide [mart.]

    67. Schembl22088

    68. Nateglinide [usp-rs]

    69. Nateglinide [who-dd]

    70. Nateglinide Impurity C [ep]

    71. Mls000759500

    72. Mls001424043

    73. Mls003915639

    74. Mls006011429

    75. Bidd:gt0257

    76. Nateglinide Cis-isomer [usp]

    77. Schembl303827

    78. Nateglinide [ema Epar]

    79. Gtpl6833

    80. Schembl7880361

    81. Schembl9232138

    82. Zinc9689

    83. Nateglinide (jp17/usp/inn)

    84. Chembl2114389

    85. Dtxsid9040687

    86. Schembl13753829

    87. Chebi:94617

    88. Nateglinide [orange Book]

    89. Hms2051g20

    90. Hms2089a10

    91. Hms2235o08

    92. Hms3675g17

    93. Hms3715f12

    94. N-(trans-4-isopropylcylolohexylcarboxyl)-d-phenylpropylicacid

    95. Nateglinide [ep Monograph]

    96. Nateglinide [usp Monograph]

    97. Bcp28400

    98. Carboxamido)-3-phenylpropanoic Acid

    99. Hy-b0422

    100. Tox21_111432

    101. Bbl033469

    102. Bdbm50344967

    103. S2489

    104. Stk647123

    105. Nateglinide Related Compound C [usp]

    106. Akos005577723

    107. Akos015841612

    108. Akos015960899

    109. Nateglinide, >=98% (hplc), Solid

    110. Tox21_111432_1

    111. Zinc100015346

    112. Zinc101489663

    113. Ac-1690

    114. Ccg-100898

    115. Db00731

    116. Ks-5143

    117. Nc00148

    118. Nsc 758695

    119. Ncgc00178741-03

    120. Ncgc00271534-02

    121. Ncgc00271534-03

    122. (r)-2-((1r,4r)-4-isopropylcyclohexane

    123. Nateglinide 100 Microg/ml In Acetonitrile

    124. N0912

    125. Nateglinide Cis-isomer [usp Impurity]

    126. Nateglinide Impurity C [ep Impurity]

    127. Sw197528-2

    128. D01111

    129. Ab00639979-06

    130. Ab00639979-08

    131. Ab00639979-09

    132. Ab00639979-11

    133. Ab00639979_12

    134. 816n044

    135. A801324

    136. A1-02996

    137. Q-201449

    138. Q2254797

    139. Nateglinide Related Compound C [usp Impurity]

    140. Q27166439

    141. N-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

    142. (trans-4-isopropylcyclohexane-1-carbonyl)-d-phenylalanine

    143. N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine

    144. Nateglinide, European Pharmacopoeia (ep) Reference Standard

    145. ((1r,4r)-4-isopropylcyclohexane-1-carbonyl)-d-phenylalanine

    146. 2-[(4-isopropyl-cyclohexanecarbonyl)-amino]-3-phenyl-propionic Acid

    147. N-(4alpha-isopropylcyclohexane-1alpha-yl)carbonyl-d-phenylalanine

    148. Nateglinide, United States Pharmacopeia (usp) Reference Standard

    149. (2r)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic Acid

    150. D-phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, Trans-

    151. (2r)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic Acid;nateglinide

    152. (2r)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic Acid

    153. (r)-2-rel-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoicacid

    154. N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine (nateglinide Impurity)

    2.4 Create Date
    2005-12-16
    3 Chemical and Physical Properties
    Molecular Weight 317.4 g/mol
    Molecular Formula C19H27NO3
    XLogP33.2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count6
    Exact Mass317.19909372 g/mol
    Monoisotopic Mass317.19909372 g/mol
    Topological Polar Surface Area66.4 Ų
    Heavy Atom Count23
    Formal Charge0
    Complexity393
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameNateglinide
    PubMed HealthNateglinide (By mouth)
    Drug LabelNateglinide tablets are oral antidiabetic agent used in the management of Type 2 diabetes mellitus [also known as non-insulin dependent diabetes mellitus (NIDDM) or adult-onset diabetes]. Nateglinide, (-)-N-[(trans-4-isopropylcyclohexane)carbonyl]-D-...
    Active IngredientNateglinide
    Dosage FormTablet
    RouteOral
    Strength120mg; 60mg
    Market StatusPrescription
    CompanyPar Pharm; Watson Labs; Dr Reddys Labs

    2 of 4  
    Drug NameStarlix
    PubMed HealthNateglinide (By mouth)
    Drug LabelStarlix (nateglinide) is an oral antidiabetic agent used in the management of Type 2 diabetes mellitus [also known as non-insulin dependent diabetes mellitus (NIDDM) or adult-onset diabetes]. Starlix, (-)-N-[(trans-4-isopropylcyclohexane)carbonyl]-...
    Active IngredientNateglinide
    Dosage FormTablet
    RouteOral
    Strength120mg; 60mg
    Market StatusPrescription
    CompanyNovartis

    3 of 4  
    Drug NameNateglinide
    PubMed HealthNateglinide (By mouth)
    Drug LabelNateglinide tablets are oral antidiabetic agent used in the management of Type 2 diabetes mellitus [also known as non-insulin dependent diabetes mellitus (NIDDM) or adult-onset diabetes]. Nateglinide, (-)-N-[(trans-4-isopropylcyclohexane)carbonyl]-D-...
    Active IngredientNateglinide
    Dosage FormTablet
    RouteOral
    Strength120mg; 60mg
    Market StatusPrescription
    CompanyPar Pharm; Watson Labs; Dr Reddys Labs

    4 of 4  
    Drug NameStarlix
    PubMed HealthNateglinide (By mouth)
    Drug LabelStarlix (nateglinide) is an oral antidiabetic agent used in the management of Type 2 diabetes mellitus [also known as non-insulin dependent diabetes mellitus (NIDDM) or adult-onset diabetes]. Starlix, (-)-N-[(trans-4-isopropylcyclohexane)carbonyl]-...
    Active IngredientNateglinide
    Dosage FormTablet
    RouteOral
    Strength120mg; 60mg
    Market StatusPrescription
    CompanyNovartis

    4.2 Drug Indication

    For the treatment of non-insulin dependent-diabetes mellitus in conjunction with diet and exercise.

    FDA Label

    Nateglinide is indicated for combination therapy with metformin in type-2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.

    Nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Insulin secretion by pancreatic cells is partly controlled by cellular membrane potential. Membrane potential is regulated through an inverse relationship between the activity of cell membrane ATP-sensitive potassium channels (ABCC8) and extracellular glucose concentrations. Extracellular glucose enters the cell via GLUT2 (SLC2A2) transporters. Once inside the cell, glucose is metabolized to produce ATP. High concentrations of ATP inhibit ATP-sensitive potassium channels causing membrane depolarization. When extracellular glucose concentrations are low, ATP-sensitive potassium channels open causing membrane repolarization. High glucose concentrations cause ATP-sensitive potassium channels to close resulting in membrane depolarization and opening of L-type calcium channels. The influx of calcium ions stimulates calcium-dependent exocytosis of insulin granules. Nateglinide increases insulin release by inhibiting ATP-sensitive potassium channels in a glucose-dependent manner.

    5.2 MeSH Pharmacological Classification

    Hypoglycemic Agents

    Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Active Moiety
    NATEGLINIDE
    5.3.2 FDA UNII
    41X3PWK4O2
    5.3.3 Pharmacological Classes
    Potassium Channel Antagonists [MoA]; Glinide [EPC]
    5.4 ATC Code

    A10BX03

    A10BX03

    A - Alimentary tract and metabolism

    A10 - Drugs used in diabetes

    A10B - Blood glucose lowering drugs, excl. insulins

    A10BX - Other blood glucose lowering drugs, excl. insulins

    A10BX03 - Nateglinide

    5.5 Absorption, Distribution and Excretion

    Absorption

    Rapidly absorbed following oral administration prior to a meal, absolute bioavailability is estimated to be approximately 73%. Peak plasma concentrations generally occur within 1 hour of oral administration. Onset of action is <20 minutes and the duration of action is approximately 4 hours.

    Route of Elimination

    Urine (83%) and feces (10%)

    Volume of Distribution

    10 liters in healthy subjects

    5.6 Metabolism/Metabolites

    Hepatic, via cytochrome P450 isoenzymes CYP2C9 (70%) and CYP3A4 (30%). Metabolism is via hydroxylation followed by glucuronidation. The major metabolites have less antidiabetic activity than nateglinide, but the isoprene minor metabolite has antidiabetic activity comparable to that of nateglinide.

    Nateglinide has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoyl]oxyoxane-2-carboxylic acid.

    S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560

    5.7 Biological Half-Life

    1.5 hours

    5.8 Mechanism of Action

    Nateglinide activity is dependent on the presence functioning cells and glucose. In contrast to sulfonylurea insulin secretatogogues, nateglinide has no effect on insulin release in the absence of glucose. Rather, it potentiates the effect of extracellular glucose on ATP-sensitive potassium channel and has little effect on insulin levels between meals and overnight. As such, nateglinide is more effective at reducing postprandial blood glucose levels than fasting blood glucose levels and requires a longer duration of therapy (approximately one month) before decreases in fasting blood glucose are observed. The insulinotropic effects of nateglinide are highest at intermediate glucose levels (3 to 10 mmol/L) and it does not increase insulin release already stimulated by high glucose concentrations (greater than 15 mmol/L). Nateglinide appears to be selective for pancreatic cells and does not appear to affect skeletal or cardiac muscle or thyroid tissue.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642703400,"product":"NATEGLINIDE PH.EUR","address":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT","city":"AHMEDABAD","supplier":"CADILA PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER","customerCountry":"TURKEY","quantity":"125.00","actualQuantity":"125","unit":"KGS","unitRateFc":"210","totalValueFC":"28526","currency":"EURO","unitRateINR":17000,"date":"21-Jan-2022","totalValueINR":"2125000","totalValueInUsd":"28526","indian_port":"AHMEDABAD AIR","hs_no":"29379020","bill_no":"7625660","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652985000,"product":"NATEGLINIDE BATCH NO.N220030001 TO N2200","address":"SCO.850, SHIVALIK ENCLAVE, NAC,,MA NIMAJRA,","city":"CHANDIGARH,CHANDIGARH","supplier":"IND SWIFT LABORATORIES LIMITED","supplierCountry":"INDIA","foreign_port":"PHILADELPHIA METROP","customer":"STRIDES PHARMACEUTICAL","customerCountry":"UNITED STATES","quantity":"637.00","actualQuantity":"637","unit":"KGS","unitRateFc":"350","totalValueFC":"213234.7","currency":"USD","unitRateINR":25871.271585557301,"date":"20-May-2022","totalValueINR":"16480000","totalValueInUsd":"213234.7","indian_port":"DELHI AIR","hs_no":"29225090","bill_no":"1526526","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"SCO.850, SHIVALIK ENCLAVE, NAC,,MA NIMAJRA,, CHANDIGARH,CHANDIGARH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674757800,"product":"NATEGLINIDE","address":"PLOT NO.135, DR.NO.10-153\/1,","city":"VISAKHAPATNAM, ANDHRA PRADESH","supplier":"EISAI PHARMACEUTICALS INDIA PVT LTD","supplierCountry":"INDIA","foreign_port":"NARITA APT\/TOKYO","customer":"EISAI CO LTD","customerCountry":"JAPAN","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"105.7","totalValueFC":"312.3","currency":"USD","unitRateINR":8511.3333333333339,"date":"27-Jan-2023","totalValueINR":"25534","totalValueInUsd":"312.3","indian_port":"Vizag-RPCIPL SEZ","hs_no":"29242990","bill_no":"4000070","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-RPCIPL SEZ","supplierAddress":"PLOT NO.135, DR.NO.10-153\/1,, VISAKHAPATNAM, ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677781800,"product":"NATEGLINIDE BATCH NO. O220030005 TO O220","address":"SCO.850, SHIVALIK ENCLAVE, NAC,,MA NIMAJRA,","city":"CHANDIGARH,CHANDIGARH","supplier":"IND SWIFT LABORATORIES LIMITED","supplierCountry":"INDIA","foreign_port":"PHILADELPHIA METROP","customer":"STRIDES PHARMACEUTICAL","customerCountry":"UNITED STATES","quantity":"635.16","actualQuantity":"635.16","unit":"KGS","unitRateFc":"350","totalValueFC":"220898.7","currency":"USD","unitRateINR":28605.390767680587,"date":"03-Mar-2023","totalValueINR":"18169000","totalValueInUsd":"220898.7","indian_port":"DELHI AIR","hs_no":"29225090","bill_no":"8216683","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"SCO.850, SHIVALIK ENCLAVE, NAC,,MA NIMAJRA,, CHANDIGARH,CHANDIGARH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684953000,"product":"NATEGLINIDE PH EUR","address":"UNICHEM BHAVAN S. V. ROAD JOGESHWARI WEST Contact No: 9198677","city":"MUMBAI","supplier":"UNICHEM LABORATORIES LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA ILAC SANAYI VE TICARET A S","customerCountry":"TURKEY","quantity":"731.14","actualQuantity":"731.14","unit":"KGS","unitRateFc":"195","totalValueFC":"141266.5","currency":"USD","unitRateINR":15898.459939272916,"date":"25-May-2023","totalValueINR":"11624000","totalValueInUsd":"141266.5","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"0","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"UNICHEM BHAVAN S. V. ROAD JOGESHWARI WEST Contact No: 9198677, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1685471400,"product":"PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL PRODUCT NATEGLINIDE PH EUR","address":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT","city":"AHMEDABAD","supplier":"CADILA PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER","customerCountry":"TURKEY","quantity":"800.00","actualQuantity":"800","unit":"KGS","unitRateFc":"210","totalValueFC":"178357.4","currency":"EURO","unitRateINR":18345,"date":"31-May-2023","totalValueINR":"14676000","totalValueInUsd":"178357.4","indian_port":"AHMEDABAD AIR","hs_no":"29379020","bill_no":"0","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698690600,"product":"PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL PRODUCT- NATEGLINIDE PH.EUR","address":"CADILA CORPORATE CAMPUS","city":"AHMEDABAD, GUJARAT","supplier":"CADILA PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER","customerCountry":"TURKEY","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"210","totalValueFC":"107834.6","currency":"EURO","unitRateINR":17950,"date":"31-Oct-2023","totalValueINR":"8975000","totalValueInUsd":"107834.6","indian_port":"Ahmedabad Air","hs_no":"29379020","bill_no":"5008842","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"CADILA CORPORATE CAMPUS, AHMEDABAD, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721068200,"product":"PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL PRODUCT - NATEGLINIDE PH.EUR","address":"CADILA CORPORATE CAMPUS","city":"AHMEDABAD, GUJARAT","supplier":"CADILA PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"GUATEMALA CITY","customer":"TO THE ORDER OF","customerCountry":"GUATEMALA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"380","totalValueFC":"731.8","currency":"USD","unitRateINR":20389.959999999999,"date":"16-Jul-2024","totalValueINR":"61169.88","totalValueInUsd":"731.8","indian_port":"Ahmedabad Air","hs_no":"29241900","bill_no":"2460290","productDescription":"API","marketType":"","country":"GUATEMALA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"CADILA CORPORATE CAMPUS, AHMEDABAD, GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1738002600,"product":"NATEGLINIDE PH.EUR","address":"UNICHEM BHAVAN, S. V. ROAD","city":"MUMBAI,MAHARASHTRA.","supplier":"UNICHEM LABORATORIES LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA ILAC SANAYI VE TICARET AS","customerCountry":"TURKEY","quantity":"276.85","actualQuantity":"276.85","unit":"KGS","unitRateFc":"205","totalValueFC":"54708.8","currency":"USD","unitRateINR":17039.88343868521,"date":"28-Jan-2025","totalValueINR":"4717491.73","totalValueInUsd":"54708.8","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"7669079","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"UNICHEM BHAVAN, S. V. ROAD, MUMBAI,MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742322600,"product":"NATEGLINIDE PH.EUR.","address":"UNICHEM BHAVAN, S. V. ROAD","city":"MUMBAI,MAHARASHTRA.","supplier":"UNICHEM LABORATORIES LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA ILAC SANAYI VE TICARET AS","customerCountry":"TURKEY","quantity":"372.61","actualQuantity":"372.61","unit":"KGS","unitRateFc":"205","totalValueFC":"74680.3","currency":"USD","unitRateINR":17360.305037438608,"date":"19-Mar-2025","totalValueINR":"6468623.26","totalValueInUsd":"74680.3","indian_port":"Bombay Air","hs_no":"29242990","bill_no":"9125718","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"UNICHEM BHAVAN, S. V. ROAD, MUMBAI,MAHARASHTRA.","customerAddress":""}]
    21-Jan-2022
    19-Mar-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - 120MG **Federal Regist...DOSAGE - TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 21204

    read-more

    DOSAGE - TABLET;ORAL - 60MG **Federal Registe...DOSAGE - TABLET;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 21204

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Granulation

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Topical

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Looking for 105816-06-6 / Nateglinide API manufacturers, exporters & distributors?

    Nateglinide manufacturers, exporters & distributors 1

    36

    PharmaCompass offers a list of Nateglinide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nateglinide manufacturer or Nateglinide supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nateglinide manufacturer or Nateglinide supplier.

    PharmaCompass also assists you with knowing the Nateglinide API Price utilized in the formulation of products. Nateglinide API Price is not always fixed or binding as the Nateglinide Price is obtained through a variety of data sources. The Nateglinide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Nateglinide

    Synonyms

    105816-04-4, Starlix, Senaglinide, Starsis, Fastic, Ay-4166

    Cas Number

    105816-06-6

    Unique Ingredient Identifier (UNII)

    XTM4DQP5S5

    About Nateglinide

    A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.

    N0912 Manufacturers

    A N0912 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N0912, including repackagers and relabelers. The FDA regulates N0912 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N0912 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of N0912 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    N0912 Suppliers

    A N0912 supplier is an individual or a company that provides N0912 active pharmaceutical ingredient (API) or N0912 finished formulations upon request. The N0912 suppliers may include N0912 API manufacturers, exporters, distributors and traders.

    click here to find a list of N0912 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    N0912 USDMF

    A N0912 DMF (Drug Master File) is a document detailing the whole manufacturing process of N0912 active pharmaceutical ingredient (API) in detail. Different forms of N0912 DMFs exist exist since differing nations have different regulations, such as N0912 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A N0912 DMF submitted to regulatory agencies in the US is known as a USDMF. N0912 USDMF includes data on N0912's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N0912 USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of N0912 suppliers with USDMF on PharmaCompass.

    N0912 JDMF

    The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

    The N0912 Drug Master File in Japan (N0912 JDMF) empowers N0912 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

    PMDA reviews the N0912 JDMF during the approval evaluation for pharmaceutical products. At the time of N0912 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

    click here to find a list of N0912 suppliers with JDMF on PharmaCompass.

    N0912 CEP

    A N0912 CEP of the European Pharmacopoeia monograph is often referred to as a N0912 Certificate of Suitability (COS). The purpose of a N0912 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N0912 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N0912 to their clients by showing that a N0912 CEP has been issued for it. The manufacturer submits a N0912 CEP (COS) as part of the market authorization procedure, and it takes on the role of a N0912 CEP holder for the record. Additionally, the data presented in the N0912 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N0912 DMF.

    A N0912 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N0912 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of N0912 suppliers with CEP (COS) on PharmaCompass.

    N0912 WC

    A N0912 written confirmation (N0912 WC) is an official document issued by a regulatory agency to a N0912 manufacturer, verifying that the manufacturing facility of a N0912 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting N0912 APIs or N0912 finished pharmaceutical products to another nation, regulatory agencies frequently require a N0912 WC (written confirmation) as part of the regulatory process.

    click here to find a list of N0912 suppliers with Written Confirmation (WC) on PharmaCompass.

    N0912 NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N0912 as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for N0912 API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture N0912 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain N0912 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N0912 NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of N0912 suppliers with NDC on PharmaCompass.

    N0912 GMP

    N0912 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of N0912 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N0912 GMP manufacturer or N0912 GMP API supplier for your needs.

    N0912 CoA

    A N0912 CoA (Certificate of Analysis) is a formal document that attests to N0912's compliance with N0912 specifications and serves as a tool for batch-level quality control.

    N0912 CoA mostly includes findings from lab analyses of a specific batch. For each N0912 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    N0912 may be tested according to a variety of international standards, such as European Pharmacopoeia (N0912 EP), N0912 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N0912 USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search